Angiotensin I-converting enzyme insertion/deletion polymorphism: Clinical implications

Acta Clinica Belgica

Volumn 52, Issue 6, 1997, Pages 338-349

  Wuyts, B ^a   Delanghe, J ^a   De Buyzere, M ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

CARDIOVASCULAR DISEASE; CAROTID ARTERY DISEASE; CEREBROVASCULAR DISEASE; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; ETHNOLOGY; GENETIC POLYMORPHISM; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; REVIEW; SARCOIDOSIS;

EID: 0031454043     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1080/17843286.1997.11718599     Document Type: Review

References (103)

1. Alhenc-Gelas F, Soubrier F, Hubert C, Allegrini J, Lattion AL, Corvol P. The angiotensin I-converting enzyme (kininase II): Progress in molecular and genetic structure. J Cardiovasc Pharmacol. 1990; 15 (suppl 6): S25-S29
2. Bénéteau-Burnat B, Baudin B. Angiotensin-converting enzyme: clinical applications and laboratory investigations on serum and other biological fluids. Crit Rev Clin Lab Sci. 1991; 28: 337-56
3. Costerousse O, Jaspard E, Wei L, Corvol P, Alhenc-Gelas F. The Angiotensin I-converting Enzyme (kininase II): Molecular organization and regulation of its expression in humans. J Cardiovasc Pharmacol. 1992; 20 (suppl 9): S10-S15
4. Dzau VJ. Local expression and pathophysiological role of renin-angiotensin in the blood vessels and hearts. Basic Res Cardiol. 1993; 88 (suppl 1): 1-14
5. Tiret L, Rigat B, Visvikis S et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992; 51: 197-205
6. Cambien F, Poirier O, Lecerf L et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992; 359: 641-4
7. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorfism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990; 86: 1343-6
8. Alhenc-Gelas F, Richard J, Courbon D, Warnet JM, Corvol P. Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters. J Lab Clin Med. 1991; 117: 33-9
9. Lee EJD. Population genetics of the angiotensin-converting enzyme in Chinese. Br J Clin Pharmac. 1994; 37: 212-4
10. Higashimori K, Zhao Y, Higaki J et al. Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. Biochem Biophys Res Commun. 1993; 191: 399-404
11. Morris BJ, Zee R, Schrader A. Different frequencies of angiotensin-converting enzyme in genotypes in older hypertensive individuals. J Clin Invest. 1994; 94: 1085-9
12. Agerhom-Larsen B, Nordestgaard BG, Steffensen R et al. ACE gene polymorphism: ischemic heart disease and longevity in 10 150 individuals. Circulation. 1997; 95 (10): 2358-67
13. Lindpaintner K, Pfeffer MA, Kreutz R et al. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995; 332: 706-11
14. Friedl W, Krempler F, Paulweber B, Pichler M, Sandhofer F. A deletion polymorphism of the angiotensin I-converting enzyme is associated with coronary heart disease in an Austrian population. Atherosclerosis. 1995; 112: 137-43
15. Kupari M, Perola M, Koskinen P, Virolainen J, Karhunen PJ. Left ventricular size, mass, and function in relation to angiotensin-convertmg enzyme gene polymorphism in humans. Am J Physiol. 1994; 36: H1107-11
16. Barley J, Blackwood A, Miller M et al. Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin. J Hypertens. 1994; 12: 955-7
17. Rutledge DR, Browe CS, Ross EA. Frequencies of the angiotensinogen gene and angiotensin I converting enzyme (ACE) gene polymorphisms in African Americans. Biochem-Mol-Biol-Int. 1994; 34: 1271-5
18. Arbustini E, Grasso M, Leo G et al. Polymorphism of angiotensin-converting enzyme gene in sarcoidosis. Am J Resp Crit Care Med. 1996; 153:851-4
19. Zee RYL, Lou Y-K, Griffiths LR, Morris BJ. Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun. 1992; 184: 9-15
20. Lachurié M-L, Azizi M, Guyenen T-T, Alhenc-Gelas F, Ménard J. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation. 1995; 91: 2933-42
21. Schachter F, Faure-Delanef L, Guenot F et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet. 1994 Jan; 6: 29-32
22. Galinsky D, Tysoe C, Brayne CE et al. Analysis of the apoE/apoC-1, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity. Atherosclerosis. 1997; 129: 177-83
23. Amant C, Bauters C, Bodart J-C et al. D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation. 1997; 96 (1): 56-60
24. Gu XX, Spaepen M, Guo C et al. Lack of association between the I/D polymorphism of the angiotensin-converting enzyme gene and essential hypertension in a Belgian population. J Hum Hypertens. 1994; 8: 683-5
25. Wuyts B, Delanghe J, De Buyzere M, Duprez D, Leroux-Roels G. Association between angiotensin I converting enzyme and rheologic variables in essential hypertension. Hypertension. 1996; 28: 688
26. Schmidt S, van Hooft IMS, Grobbee DE, Ganten D, Ritz E. Polymorphism of the angiotensin I-converting enzyme gene is apparently not related to high blood pressure: Dutch hypertension and offspring study. J Hypertens. 1993; 11: 345-8
27. Vassilikioti S, Doumas M, Douma S et al. Angiotensin converting enzyme gene polymorphism is not related to essential hypertension in a Greek population. Am J Hypertens. 1996; 9: 700-2
28. Kamdar S, Daniel H, Fagarty P, Lawson M, Munroe P, Caulfield M. ACE insertion/deletion (I/D) polymorphism in Vincentian African Caribbeans with essential hypertension. J Hum Hypertens. 1994; 8: 611
29. Elsahat YI, Obineche EN, Lestringant GG, Frossard PM. An angiotensin converting enzyme gene polymorphism does not correlate with hypertension in an Arab population from the United Arab Emirates. Am J Hum Genet. 1995; 57: A238
30. Asamoah A, Yanamandra K, Thurmon TF et al. A deletion in the angiotensin converting enzyme (ACE) gene is common among African Americans with essential hypertension. Clin Chim Acta. 1996; 254: 41-6
31. Barley J, Blackwood A, Miller M et al. Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renine-angiotensin system in Caucasian and Afro-Caribbean peoples. J Hum Hypertens. 1996; 10: 31-5
32. Duru K, Farrow S, Wang JM, Lockette W, Kurtz T. Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension. Am J Hypertens. 1994; 7: 759-62
33. Hingorani AD, Jia H, Stevens PA, Hopper R, Dickerson C, Brown MJ. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertens. 1995; 13: 1602-9
34. Kojima S, Inenaga T, Matsuoka H et al. The association between salt sensitivity of blood pressure and some polymorphic factors. J Hypertens. 1994; 12: 797-801
35. Hiraga H, Oshima T, Watanabe M et al. Angiotensin I-converting enzyme gene polymorphism and salt sensitivity in essential hypertension. Hypertension. 1996; 27: 569-72
36. Dudley C, Keavney B, Casadei B, Conway J, Bird R, Ratcliff P. Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: investigation of renin-angiotensin system genes. J Hypertens. 1996; 14: 259-62
37. Gharavi AG, Lipkowitz MS, Diamond JA, Jhang JS, Phillips RA. Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension. Am J Cardiol. 1996; 77: 1315-9
38. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD-genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation. 1994; 90: 2622-8
39. Schunkert K, Hense H-W, Holmer SR et al. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left venticular hypertrophy. N Engl J Med. 1994; 330: 1634-8
40. Montgomery HE, Clarkson P, Dollery CM et al. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation. 1997; 96 (3): 741-7
41. Lindpaintner K, Lee M, Larson MG et al. Absence of association or genetic linkage between the angiotensin-converting enzyme gene and left ventricular mass. N Engl J Med. 1996; 334: 1023-8
42. Prasad N, O'Kane KPJ, Johnstone HA et al. The relationship between blood pressure and left ventricular mass in essential hypertension is observed only in the presence of the angiotensin-converting enzyme gene deletion allele. Q J Med. 1994; 87: 659-62
43. Lindpaintner K, Lee M, Larson MG et al. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med. 1996; 334: 1023-8
44. Montgomery HE, Keeling PJ, Goldman JH, Humphries SE, Talmud PJ, McKenna WJ. Lack of association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1995; 25: 1627-31
45. Sanderson JE, Young RP, Yu CM, Chan S, Critchley J, Woo KS. Lack of association between insertion / deletion polymorphism of the angiotensin-converting enzyme gene and end-stage heart failure due to ischemic or idiopathic dilated cardiomyopathy in the Chinese. Am J Cardiol. 1996; 77: 1008-10
46. Ham HJ, Chang CY, Ho LI et al. Evidence that polymorphism of the angiotensin I converting enzyme gene may be related to idiopathic dilated cardiomyopathy in the Chinese population. Biochem Mol Biol Int. 1995; 35: 1175-81
47. Lindpaintner K, Pfeffer M. Molecular genetics crying wolf? The case of the angiotensin-converting enzyme gene and cardiovascular disease. J Am Coll Cardiol. 1995; 25: 1632-3
48. Andersson B, Sylvén C. The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure. J Am Coll Cardiol. 1996; 28:162-7
49. Marian AJ, Yu Q-T, Workman R, Greve G, Roberts R, Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet. 1993; 342: 1085-6
50. Lechin M, Quiñones M A, Omran A et al. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation. 1995; 92: 1808-12
51. Evans AD, Patterson CC, Mathewson Z, MeCrum EE, Mcllmoyle EL. Incidence, delay and survival in the Belfast MONICA project coronary event register. Rev Epidémiol Santé Publique. 1990; 38: 419-27
52. Evans A, Poirier O, Kee F et al. Polymorphisms of the angiotensin-converting enzyme gene in subjects who die from coronary heart disease. Q J Med. 1994; 87: 211-4
53. Leatham E, Barley J, Redwood S et al. Angiotensin-I converting enzyme (ACE) polymorphism in patients presenting with myocardial infarction or unstable angina. J Hum Hypertens. 1994; 8: 635-8
54. Tiret L, Kee F, Poirier O et al. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet. 1993; 341: 991-2
55. Bohn M, Berge DE, Bakken A, Erikssen J, Berg K. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin Genet. 1993; 44: 292-7
56. Bohn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion / Deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and parental history of myocardial infarction. Clin Genet. 1993; 44: 298-301
57. Keavney BD, Dudley CRK, Stratton IM et al. UK Prospective Diabetes Study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM. Diabetologia. 1995; 38: 948-52
58. Gardemann A, Weiss T, Schwartz O et al. Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients. Circulation. 1995; 92: 2796-9
59. Perola M, Sajantila A, Sarti C et al. Angiotensin-converting enzyme genotypes in the high- and low-risk area for coronary heart disease in Finland. Genet Epidemiol. 1995; 12: 391-9
60. Cambien F, Costerousse O, Tiret L et al. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation. 1994; 90: 669-76
61. Singer DRJ, Missouris CG, Jeffery S. Angiotens in-converting enzyme gene polymorphism. What to do about all the confusion? Circulation. 1996; 94: 236-9
62. Samani NJ, Thompson JR, O' Toole L, Channer K, Woods KL. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation. 1996; 94: 708-12
63. Nakai K, Itoh C, Miura Y et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation. 1994; 90: 2199-202
64. Ruiz J, Blanché H, Cohen N et al. Insertion/deletion polymorphism of the coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA. 1994; 91: 3662-5
65. Badenshop FF, Wang XL, Wilchen D. Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation. 1995; 91: 1655-8
66. Mattu RK, Needham E, Galton DJ, Frangos E, Clark A, Caulfieid M. A DNA variant at het angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation. 1995; 91: 270-4
67. Ludwig E, Corneli PS, Anderson FL, Marshall HW, Lalouel J-M, Ward RH. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation. 1995; 91: 2120-4
68. Wang XL, McCredie RM, Wilcken DEL. Genotype distribution of angiotensin-converting enzyme polymorphism in Australian healthy and coronary populations and relevance to myocardial infarction and coronary artery disease. Arterioscler Thromb Vasc Biol. 1996; 16: 115-9
69. Miettinen HE, Korpela K, Hämäläinen L, Kontula K. Polymorphism of the apolipoprotein and angiotensin converting enzyme genes in young North Karelian patients with coronary heart disease. Hum Genet. 1994; 94: 189-92
70. Katsuya T, Koike G, Yee TW et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet. 1995; 345: 1600-3
71. Panahloo A, Andrès C, Mohamed-Ali V et al. The insertion allele of the ACE gene I/D polymorphism: a candidate gene for insulin resistance? Circulation. 1995; 92: 3390-3
72. Zhang Y, Jeffery S, Barley J, Hann C, Carter N, Kaski JC. Angiotensin-converting enzyme insertion / deletion polymorphism in angina pectoris with normal coronary arteriograms. Am J Cardiol. 1996; 77: 877-9
73. Kaski JC, Zhang Y, Calvino R et al. Angiotensin-converting enzyme insertion / deletion polymorphism and restenosis after coronary angioplasty in unstable angina pectoris. Am J Cardiol. 1996; 77: 875-9
74. Samani NJ, Martin DS, Brack M et al. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty. Lancer. 1995; 345: 1013-6
75. Hamon M, Amant C, Bauters C, Lablanche J-M, Bertrand M, Amouyel P. ACE polymorphism, a genetic predictor of occlusion after coronary angioplasty. Am J Cardiol. 1996; 78: 679-81
76. Hamon M, Bauters C, Amant C et al. Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty. Circulation. 1995; 92: 296-9
77. Beohar N, Damaraju S, Prather A et al. Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease. J Investig Med. 1995; 43: 275-80
78. Catto A, Carter A, Barret J et al. Angiotensin converting enzyme insertion / deletion polymorphism. Stroke. 1996; 27: 435-40
79. Ueda S, Elliott HL, Morton JJ, Connell J. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype for angiotensin-converting enzyme. Hypertension. 1995; 25: 1266-9
80. Kario K, Nobuyuki K, Saito K, Nago N, Matsuo T, Shimada K. Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation. 1996; 93: 1630-3
81. Ueda S, Weir CJ, Inglis GC, Murray GC, Muir KW, Lees DR. Lack of association between angiotensin converting enzyme gene insertion/deletion polymorphism and stroke. J Hypertens. 1995; 13: 1596-601
82. Markus HS, Barley J, Lunt R et al. Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. Stroke. 1995; 26: 1329-33
83. Sharma P, Carter ND, Barley J, Brown MM. Molecular approach to assessing the genetic risk of cerebral infarction: deletion polymorphism in the gene encoding angiotensin I-converting enzyme. J Hum Hypertens. 1994; 8: 645-8
84. Bonithon-Kopp C, Ducimetiere P, Touboul PJ et al. Plasmaangiotensin-converting enzyme activity and carotid wall thickening. Circulation. 1994; 89: 952-4
85. Castellano M, Muiesan ML, Rizzoni D et al. Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population. Circulation. 1995; 91: 2721-4
86. Hosoi M, Nishizawa Y, Kogawa K et al. Angiotensin-converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin dependent diabetic patients. Circulation. 1996; 94: 704-7
87. Dessì-Fulgheri P, Catalini R, Sarzani R et al. Angiotensin converting enzyme gene polymorphism and carotid atherosclerosis in a low-risk population. J Hypertens. 1995; 13: 1593-6
88. Kario K, Kanai N, Nishiuma S et al. Hypertensive nephropathy and the gene for angiotensin-converting enzyme. Atherioscler Thromb Vasc Biol. 1997; 17: 252-6
89. Marre M, Bernadet P, Gallois Y et al. Relationships between angiotensin I-converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes. 1994; 43: 384-8
90. Ohno T, Kawazu S, Tomono S. Association analyses of the polymorphism of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism. 1996; 45; 218-22
91. Doria A, Warram J H, Krolewski A S. Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I-converting enzyme gene. Diabetes. 1994; 43: 690-5
92. Tarnow L, Cambien F, Rossing P et al. Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia. 1995; 38: 798-803
93. Nagi DK, Mansfield MW, Stickland MH, Grant PJ. Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism, and diabetic retinopathy in subjects with IDDM and NIDDM. Diabet Med. 1995; 12: 997-1001
94. Tarnow L, Cambien F, Rossing P et al. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes. 1995; 44: 489-94
95. Fujisawa T, Ikegami H, Shen GQ et al. Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care. 1995; 18: 983-5
96. Schmidt S, Stier E, Hartung R et al. No association of converting enzyme insertion/deletion polymorphism with immunoglobin A glomerulonephritis. Am J Kidney Dis. 1995; 26: 727-31
97. Yoshida H, Mitarai T, Kawamura T et al. Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest. 1995; 96: 2162-9
98. Harden PN, Geddes C, Rowe PA et al. Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet. 1995; 345: 1540-2
99. van Essen GG, Rensma PL, de Zeeuw D, Sluiter WJ, Scheffer H, Apperloo AJ. Association between angiotensin-converting enzyme gene polymorphism and failure of renoprotective therapy. Lancet. 1996; 347: 94-5
100. Soubrier F, Nadaud S, Williams TA. Angiotensin I converting enzyme gene: regulation, polymorphism and implications in cardiovascular diseases. Eur Heart J. 1994; 15 (suppl D): 24-9
101. Sharma P, Carter ND, Barley J, Lunt R, Seymour CA, Brown MM. Polymorphisms in the gene encoding angiotensin I-converting enzyme and reationship to its post-translational product in cerebral infarction. J Hum Hypertens. 1994; 8: 633-4
102. Bloem LJ, Manatunga AK, Pratt JH. Racial difference in the relationship of an angiotensin I-converting enzyme polymorphism activity. Hypertension. 1996; 27: 62-6
103. Arbusini E, Grasso M, Fasani R et al. Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. Br Heart J. 1995; 74: 584-91